| |
| | Purdue Begins Shipment of Palladone (hydromorphone HCl extended-release) Capsules (CII) |
 | | While long-acting (q12h) hydromorphone formulations are available in Canada, the United Kingdom, and Germany, Palladone is the first long-acting hydromorphone formulation available in the U.S. The product offers the convenience of once-daily (q24h) dosing and will be available in 12 mg, 16 mg, 24 mg, and 32 mg dosage strengths. |
 | | Palladone™ (hydromorphone HCl extended-release) Capsules are indicated for the management of persistent, moderate to severe pain in patients requiring continuous, around-the-clock analgesia with a high potency opioid for an extended period of time (weeks to months) or longer. |
 | | Schedule II opioid agonists (which include hydromorphone, fentanyl, methadone, morphine, oxycodone, and oxymorphone), have the highest risk of fatal overdoses due to respiratory depression, as well as the highest potential for abuse. |
| www.pharma.com /pressroom/news/20050107-02.htm (1553 words) |
|